- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT01915121
An Educational Intervention for Patients With Bladder Cancer
An Educational Intervention for Patients With Bladder Cancer 121193-MRSG-11-103-01-CPPB American Cancer Society
The study main objectives are to enhance treatment decision making and improve quality of life and post-treatment health care among patients diagnosed with invasive bladder cancer.
Bladder cancer (BL Ca) is the 5th most commonly diagnosed cancer in the US . BL Ca is more common among men than women and 90% of all patients are over the age of 55. Surgery to remove the bladder followed by one of three diversion techniques (i.e., ileal conduit, continent reservoir, and neobladder) is the standard therapy following invasive bladder cancer. The emotional, functional, physical, and social impact of invasive Bl Ca treatment on patients' QOL and adjustment can be devastating. This impact significantly varies by treatment option. Treatment decision making in for BL Ca is difficult at best and potentially susceptible to a number of cognitive and affective factors (e.g., patients' emotional reaction, values, and expectations). Thus, in addition to adjusting to a potential life-threatening disease, having to cope with uncertainty about the efficacy and outcomes of different treatment options adds to the overall distress and may impair effective decision-making. In spite of increasing efforts in health communication and patient education, no study has examined treatment decision making among invasive bladder patients or has provided an educational intervention to facilitate treatment decision making among this population. To this end, and guided by the Self-Regulation theory (SRT) that emphasizes the role of cognitive and emotional factors in decision making, we have designed and pilot tested the acceptability of a preliminary educational and training experiential intervention (ETE) to address this gap in the literature. The ETE intervention uses new and innovative educational strategies and methods to educate patients about their treatment options and to facilitate their treatment decision making.
연구 개요
상세 설명
The goals of the study are: 1) to further enhance the design and application of the ETE intervention, and 2) to provide data on the efficacy of the refined ETE intervention in a randomized-controlled study (RCT). To achieve these 2 goals, the study is divided in to 2 phases.
PHASE 1: To enhance and refine the design and application of the preliminary ETE intervention:
Aim 1-a: To explore knowledge, beliefs, values and expectations about treatment options, treatment decision making, and quality of life (QOL) among patients with BL Ca.
To achieve Aim 1-a of Phase 1, as a first step, 2 focus groups (FG; N = 10 each) of invasive BL Ca patients will be conducted to a) examine knowledge, beliefs, values, expectations, and affective responses about treatment options and treatment decision making, b) record difficulties and problems in post-surgical health care (e.g., using stoma appliances and catheters), and c) explore concerns patients have as they live with the impact of treatment. The ETE intervention will be refined based on FG results.
Aim 1-b: To explore patients' acceptability of the refined ETE intervention. To achieve Aim 1-b of Phase 1, additional 2 FG (FG; N = 10 each) of BL Ca survivors will be conducted to solicit input about the design and acceptability of the refined ETE intervention.
PHASE 2: Aim 2. To assess the efficacy of the ETE intervention in small RCT To achieve Aim 2 of Phase 2, a two-group RCT (standard care (SC) plus time and attention control condition, N = 62 patients; SC plus ETE intervention N = 62 patients) will be conducted to examine the efficacy of the ETE intervention. Phase 2 will provide a) a test of the efficacy of the refined ETE intervention for reducing decisional conflict and regret, and improving QOL and post-treatment stoma and pouch care controlling for potential clinical and socio-demographic covariates (e.g., treatment type, age).
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
New York
-
New York, New York, 미국, 10029
- Icahn School of Medicine at Mount Sinai
-
The Bronx, New York, 미국, 10468
- James J. Peters VA Medical Center
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Phase 1 (Focus groups/ In-depth Interview)
Inclusion Criteria:
- treatment of invasive Bladder Cancer a with cystectomy and one of the three major urinary diversion methods
- English speaking
- between the ages of 18 and 85
- able and willing to provide informed consent
- may have received neoadjuvant or adjuvant chemotherapy, radiation therapy, and immunotherapy (BCG)
Exclusion Criteria:
- metastatic disease or cancer recurrence
- presence of other primary cancers
- no access to a telephone
Phase 2 (randomized-controlled-study)
Additional Exclusion Criteria:
- treatment decision is made and /beginning/completion of treatment.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 하나의
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
---|---|
활성 비교기: Education Intervention
In this session, participant will be provided with information about bladder cancer treatment options, and training tools directly related to Bladder Cancer.
|
1-hour educational and training sessions.
In this session, participant will be provided with information about bladder cancer treatment options, and training tools directly related to Bladder Cancer.
In 4 to 5 days following the session, participants will be asked to schedule the time to talk about experience and how the intervention affects their treatment decision making and to answer some questions about the educational and training session they attended.
Participants will then be called after 1-month, 3-month, and 6-month after their bladder cancer treatment to follow up.
|
위약 비교기: Nutrition Intervention
In this session, participant will be provided with information about nutrition information directly related to bladder cancer recovery
|
1-hour educational and training sessions.
In this session, participant will be provided with nutrition information directly related to Bladder Cancer recovery.
In 4 to 5 days following the session, participants will be asked to schedule the time to talk about experience and how the intervention affects their treatment decision making and to answer some questions about the educational and training session they attended.
Participants will then be called after 1-month, 3-month, and 6-month after their bladder cancer treatment to follow up.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Decisional Regret Scale
기간: Baseline
|
The intervention is designed to enhance treatment decision making.
|
Baseline
|
Decisional Regret Scale
기간: 1 month follow up
|
The intervention is designed to enhance treatment decision making.
|
1 month follow up
|
Decisional Regret Scale
기간: 3 month follow up
|
The intervention is designed to enhance treatment decision making.
|
3 month follow up
|
Decisional Regret Scale
기간: 6 month follow up
|
The intervention is designed to enhance treatment decision making.
|
6 month follow up
|
Decisional Self-Efficacy Scale
기간: Baseline
|
The intervention is designed to enhance treatment decision making.
|
Baseline
|
Decisional Self-Efficacy Scale
기간: 1 month follow up
|
The intervention is designed to enhance treatment decision making.
|
1 month follow up
|
Decisional Self-Efficacy Scale
기간: 3 month follow up
|
The intervention is designed to enhance treatment decision making.
|
3 month follow up
|
Decisional Self-Efficacy Scale
기간: 6 month follow up
|
The intervention is designed to enhance treatment decision making.
|
6 month follow up
|
Treatment-related Values
기간: Baseline
|
The intervention is designed to enhance treatment decision making.
|
Baseline
|
Treatment-related Values
기간: 1 month follow up
|
The intervention is designed to enhance treatment decision making.
|
1 month follow up
|
Treatment-related Values
기간: 3 month follow up
|
The intervention is designed to enhance treatment decision making.
|
3 month follow up
|
Treatment-related Values
기간: 6 month follow up
|
The intervention is designed to enhance treatment decision making.
|
6 month follow up
|
Decisional Regret Scale
기간: Baseline
|
Bladder Cancer knowledge Scale The intervention is designed to enhance treatment decision making. |
Baseline
|
Decisional Regret Scale
기간: 1 month follow up
|
Bladder Cancer knowledge Scale The intervention is designed to enhance treatment decision making. |
1 month follow up
|
Decisional Regret Scale
기간: 3 month follow up
|
Bladder Cancer knowledge Scale The intervention is designed to enhance treatment decision making. |
3 month follow up
|
Decisional Regret Scale
기간: 6 month follow up
|
Bladder Cancer knowledge Scale The intervention is designed to enhance treatment decision making. |
6 month follow up
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
quality of life
기간: Baseline
|
FACT-BL, Emotional, physical, function, and social Wellbeing Subscales
|
Baseline
|
quality of life
기간: 1 month follow up
|
FACT-BL, Emotional, physical, function, and social Wellbeing Subscales
|
1 month follow up
|
quality of life
기간: 3 month follow up
|
FACT-BL, Emotional, physical, function, and social Wellbeing Subscales
|
3 month follow up
|
quality of life
기간: 6 month follow up
|
FACT-BL, Emotional, physical, function, and social Wellbeing Subscales
|
6 month follow up
|
post-surgical self-care
기간: Baseline
|
FACT-BL Ca additional concern
|
Baseline
|
post-surgical self-care
기간: 1 month follow up
|
FACT-BL Ca additional concern
|
1 month follow up
|
post-surgical self-care
기간: 3 month follow up
|
FACT-BL Ca additional concern
|
3 month follow up
|
post-surgical self-care
기간: 6 month follow up
|
FACT-BL Ca additional concern
|
6 month follow up
|
CES-D scale Illness Perception Questionnaire (IPQ)
기간: Baseline
|
Baseline
|
|
CES-D scale Illness Perception Questionnaire (IPQ)
기간: 1 month follow up
|
1 month follow up
|
|
CES-D scale Illness Perception Questionnaire (IPQ)
기간: 3 month follow up
|
3 month follow up
|
|
CES-D scale Illness Perception Questionnaire (IPQ)
기간: 6 month follow up
|
6 month follow up
|
|
Cancer worries scale
기간: Baseline
|
Baseline
|
|
Cancer worries scale
기간: 1 month follow up
|
1 month follow up
|
|
Cancer worries scale
기간: 3 month follow up
|
3 month follow up
|
|
Cancer worries scale
기간: 6 month follow up
|
6 month follow up
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Nihal E Mohamed, PhD, Icahn School of Medicine at Mount Sinai
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
방광암에 대한 임상 시험
-
Georgetown UniversityNational Cancer Institute (NCI); American Cancer Society, Inc.; Susan G. Komen Breast Cancer...완전한
-
University of UtahNational Cancer Institute (NCI)모병피로 | 좌식 생활 | 전이성 전립선암 | IV기 전립선암 AJCC(American Joint Committee on Cancer) v8 | IVA기 전립선암 AJCC(American Joint Committee on Cancer) v8 | IVB기 전립선암 AJCC(American Joint Committee on Cancer) v8미국
-
Jonsson Comprehensive Cancer Center아직 모집하지 않음전립선암 | IVB기 전립선암 American Joint Committee on Cancer(AJCC) v8미국
-
Rashmi Verma, MDNational Cancer Institute (NCI)모병거세저항성 전립선암 | 전이성 전립선 선암종 | IVB기 전립선암 American Joint Committee on Cancer(AJCC) v8미국
-
Jonsson Comprehensive Cancer Center빼는전립선 선암종 | 2기 전립선암 AJCC v8 | IIC기 전립선암 AJCC v8 | IIA기 전립선암 AJCC v8 | IIB기 전립선암 AJCC v8 | 1기 전립선암 American Joint Committee on Cancer(AJCC) v8미국
-
Jonsson Comprehensive Cancer CenterMiraDX모집하지 않고 적극적으로전립선 선암종 | 2기 전립선암 AJCC v8 | IIC기 전립선암 AJCC v8 | IIA기 전립선암 AJCC v8 | IIB기 전립선암 AJCC v8 | 1기 전립선암 American Joint Committee on Cancer(AJCC) v8미국
-
Jonsson Comprehensive Cancer Center종료됨거세저항성 전립선암 | 전이성 전립선암 | IVA기 전립선암 AJCC v8 | IVB기 전립선암 AJCC v8 | IV기 전립선암 American Joint Committee on Cancer(AJCC) v8미국
-
Jonsson Comprehensive Cancer CenterProgenics Pharmaceuticals, Inc.종료됨2기 전립선암 AJCC v8 | IIIA기 전립선암 AJCC v8 | IIIB기 전립선암 AJCC v8 | IIC기 전립선암 AJCC v8 | 3기 전립선암 AJCC v8 | IIIC기 전립선암 AJCC v8 | IIA기 전립선암 AJCC v8 | IIB기 전립선암 AJCC v8 | 1기 전립선암 American Joint Committee on Cancer(AJCC) v8미국
-
Assiut University아직 모집하지 않음South Egypt Cancer Institute(SECI)에서 소아 악성종양 환자에 대한 KDIGO 기준을 사용하여 AKI의 누적 발병률을 확인하기 위해
-
Jonsson Comprehensive Cancer Center종료됨생화학적으로 재발하는 전립선암 | 전이성 전립선암 | 뼈의 전이성 악성 신생물 | IVA기 전립선암 AJCC v8 | IVB기 전립선암 AJCC v8 | IV기 전립선암 American Joint Committee on Cancer(AJCC) v8미국
Education Intervention에 대한 임상 시험
-
University of SheffieldUniversity of Liverpool; University of Manchester; University of Melbourne모집하지 않고 적극적으로
-
VA Office of Research and Development모집하지 않고 적극적으로
-
Washington University School of MedicineSt. Jude Children's Research Hospital완전한
-
University of OxfordBeijing Normal University; Beijing Stars and Rain Education Institute for Autism완전한아동 학대 | 부모-자녀 관계 | 자폐 스펙트럼 장애 | 육아 | 아동 행동 문제 | 가족 관계 | 정신 건강 문제중국